[go: up one dir, main page]

FR2858233B1 - Medicament gazeux inhalable a base de xenon et de protoxyde d'azote - Google Patents

Medicament gazeux inhalable a base de xenon et de protoxyde d'azote

Info

Publication number
FR2858233B1
FR2858233B1 FR0350383A FR0350383A FR2858233B1 FR 2858233 B1 FR2858233 B1 FR 2858233B1 FR 0350383 A FR0350383 A FR 0350383A FR 0350383 A FR0350383 A FR 0350383A FR 2858233 B1 FR2858233 B1 FR 2858233B1
Authority
FR
France
Prior art keywords
xenon
medicine based
nitrogen protoxide
gas medicine
inhalable gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0350383A
Other languages
English (en)
Other versions
FR2858233A1 (fr
Inventor
Marc Lemaire
Jacques Abraini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0350383A priority Critical patent/FR2858233B1/fr
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Priority to US10/563,278 priority patent/US20070053992A1/en
Priority to EP04767913A priority patent/EP1651243A2/fr
Priority to CN2004800215351A priority patent/CN1829522B/zh
Priority to AU2004260859A priority patent/AU2004260859B2/en
Priority to JP2006521634A priority patent/JP2007500174A/ja
Priority to PCT/FR2004/050352 priority patent/WO2005011711A2/fr
Priority to CA002533499A priority patent/CA2533499A1/fr
Publication of FR2858233A1 publication Critical patent/FR2858233A1/fr
Application granted granted Critical
Publication of FR2858233B1 publication Critical patent/FR2858233B1/fr
Priority to US12/417,087 priority patent/US20090252816A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0350383A 2003-07-30 2003-07-30 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote Expired - Fee Related FR2858233B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0350383A FR2858233B1 (fr) 2003-07-30 2003-07-30 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
EP04767913A EP1651243A2 (fr) 2003-07-30 2004-07-23 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
CN2004800215351A CN1829522B (zh) 2003-07-30 2004-07-23 基于氙和一氧化二氮的可吸入性气体药物
AU2004260859A AU2004260859B2 (en) 2003-07-30 2004-07-23 Inhalable gaseous medicament based on xenon and nitrous oxide
US10/563,278 US20070053992A1 (en) 2003-07-30 2004-07-23 Inhalable gaseous medicament based on xenon and nitrous oxide
JP2006521634A JP2007500174A (ja) 2003-07-30 2004-07-23 キセノンと亜酸化窒素に基づく吸入可能なガス状医薬
PCT/FR2004/050352 WO2005011711A2 (fr) 2003-07-30 2004-07-23 Medicament gazeux inhalable a base de xenon et de protoxyde d’azote
CA002533499A CA2533499A1 (fr) 2003-07-30 2004-07-23 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
US12/417,087 US20090252816A1 (en) 2003-07-30 2009-04-02 Inhalable Gaseous Medicament Based On Xenon And Nitrous Oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0350383A FR2858233B1 (fr) 2003-07-30 2003-07-30 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote

Publications (2)

Publication Number Publication Date
FR2858233A1 FR2858233A1 (fr) 2005-02-04
FR2858233B1 true FR2858233B1 (fr) 2008-04-11

Family

ID=34043809

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0350383A Expired - Fee Related FR2858233B1 (fr) 2003-07-30 2003-07-30 Medicament gazeux inhalable a base de xenon et de protoxyde d'azote

Country Status (8)

Country Link
US (2) US20070053992A1 (fr)
EP (1) EP1651243A2 (fr)
JP (1) JP2007500174A (fr)
CN (1) CN1829522B (fr)
AU (1) AU2004260859B2 (fr)
CA (1) CA2533499A1 (fr)
FR (1) FR2858233B1 (fr)
WO (1) WO2005011711A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
FR2914632B1 (fr) * 2007-04-06 2009-12-18 Air Liquide Melange gazeux a base de o2 de n2o destine a prevenir ou a diminuer l'hyperalgesie
FR2914633A1 (fr) * 2007-04-06 2008-10-10 Air Liquide Melange gazeux a base d'oxygene et de xenon destine a prevenir ou a diminuer une hyperalgesie
US8425428B2 (en) * 2008-03-31 2013-04-23 Covidien Lp Nitric oxide measurements in patients using flowfeedback
FR2929513B1 (fr) * 2008-04-02 2010-09-17 Air Liquide Traitement des migraines sans aura chez le femmes enceintes par inhalation de dioxygene gazeux.
WO2010035074A1 (fr) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Utilisation d'oxyde de diazote, d'argon, de xénon, d'hélium ou de néon pour fabriquer une composition pharmaceutique destinée à traiter des lésions ischémiques chez des patients ne pouvant pas être traités par des agents thrombolytiques
US8652064B2 (en) * 2008-09-30 2014-02-18 Covidien Lp Sampling circuit for measuring analytes
FR2952305B1 (fr) * 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
GB2478356A (en) * 2010-03-05 2011-09-07 Esaturnus Nv Nitrous oxide gas for use in preventing adhesion
FR2960778B1 (fr) * 2010-06-03 2012-07-13 Air Liquide Medicament inhalable a base de xenon pour prevenir les rechutes addictives
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2996459B1 (fr) 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996458B1 (fr) 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) * 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
CN104337830A (zh) * 2013-11-12 2015-02-11 余建强 一种无成瘾性吸入脱毒剂
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
CN104688767B (zh) * 2015-03-17 2017-10-24 宁夏恩多芬科技有限公司 安桃乐在制备用于戒毒药物中的用途
CN108066355A (zh) * 2017-12-28 2018-05-25 宁夏恩多芬科技有限公司 Nitrous Oxide作为治疗神经官能症的用途
RU2758536C1 (ru) * 2020-12-17 2021-10-29 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ снижения воспалительной гиперактивации нейтрофилов

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1179997A1 (ru) * 1973-02-28 1985-09-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср Средство дл лечени паркинсонизма "глудантан
US3876773A (en) * 1973-05-15 1975-04-08 British Oxygen Co Ltd Gas mixtures containing nitrous oxide
FR2596989B1 (fr) * 1986-04-14 1990-05-18 Air Liquide Produit de radiosensibilisation des tissus biologiques en radiotherapie
RU2072241C1 (ru) * 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications

Also Published As

Publication number Publication date
AU2004260859B2 (en) 2009-12-24
WO2005011711A3 (fr) 2005-05-06
CN1829522B (zh) 2010-05-12
EP1651243A2 (fr) 2006-05-03
US20070053992A1 (en) 2007-03-08
US20090252816A1 (en) 2009-10-08
JP2007500174A (ja) 2007-01-11
CN1829522A (zh) 2006-09-06
FR2858233A1 (fr) 2005-02-04
WO2005011711A2 (fr) 2005-02-10
AU2004260859A1 (en) 2005-02-10
CA2533499A1 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
FR2858233B1 (fr) Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
IL166405A0 (en) 3-z-Ä1-4-(n-((4-methyl-piperazin-1-yl)methylcarbonyl)-n-methyl-aminoanilo)-1-phenyl-methyleneÜ-6-methyxycarbonyl-2-indoline-monoethanesulphonate and the use thereof as a pharmaceutical composition
EP1367060A4 (fr) Derives glucopyranosyloxybenzylbenzene et leur utilisation medicale
EP1364957A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
NO2013007I2 (no) Dapagliflozin og farmasøytisk akseptable salter derav
EP1462134A4 (fr) Instrument d'administration a usage medical
EP1509278A4 (fr) Dispositif implantable d'administration de m dicaments
EP1479666A4 (fr) Compose d'esters et ses utilisation en medecine
PL370563A1 (en) Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
AU2002357776A8 (en) Drug implant injection device
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
GB2385273B (en) Drug delivery device
IL157580A0 (en) Inhalation drug combination
IL162406A0 (en) Deuterated substituted dihydrofuranones and medicaments containing these compounds
EP1586557A4 (fr) Derives de 4-nitro-2- (4'-methoxy)-phenoxy|-methanesulfonanilide et leur utilisation a des fins pharmaceutiques
EP1654312A4 (fr) Aerosol doseur pharmaceutique et procedes associes
AU2003217782A8 (en) Dna-binding polyamide drug conjugates
NO20026055D0 (no) Farmasöytisk komponent omfattende human paratyroidhormon og farmasöytisk komponent for nasal administrering inneholdende komponentene
PL369654A1 (en) Deuterated pyrazolopyrimidinones and drugs containing said compounds
IL161163A0 (en) Anthranilic acid amides and pharmaceutical use thereof
NO20033709D0 (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
FR2820311B3 (fr) Distributeur de medicament portatif
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130329